The complex [Co(dmgH)2pyCl]2+ (1, dmgH = dimethylglyoximate, py = pridine) has been used as a molecular catalyst for visible light driven hydrogen production in the presence of [Pt(tolylterpyridine)(phenylacetylide)]+ (3) as a photosensitizer and triethanolamine (TEOA) as a sacrificial reducing agent. Complex 3 is quenched oxidatively by [Co(dmgH)pyCl]2+ (1) with a rate constant kq of 1.27 x 10(9) M(-1) s(-1). Photogeneration of H2 is only seen when 1 + 3 + TEOA are all present. H2 production is maximized for this system at pH 8.5 and declines to very low levels at pH < 7 and pH > 12. Irradiation of the reaction solution initially containing 1.61 x 10(-2) M TEOA, 1.11 x 10(-5) M of 3, and 1.99 x 10(-4) M of Co catalyst 1 in MeCN/water (3:2 v/v) at pH = 8.5 for 10 h with lambda > 410 nm yields 400 turnovers of H2. When TEOA is 0.27 M, approximately 1000 turnovers are obtained after 10 h of irradiation. Spectroscopic study of the photolyses solutions suggests that H2 formation proceeds via Co(I) and protonation to form Co(III) hydride species.
No takes yet. Share an insight, caveat, or question.
Du et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: